Aclaris Therapeutics
ACRS
#8130
Rank
โ‚น16.50 B
Marketcap
โ‚น231.10
Share price
-1.81%
Change (1 day)
159.68%
Change (1 year)

Aclaris Therapeutics (ACRS) - Total liabilities

Total liabilities on the balance sheet as of September 2024 : โ‚น4.43 Billion

According to Aclaris Therapeutics's latest financial reports the company's total liabilities are โ‚น4.43 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Aclaris Therapeutics - Total liabilities on balance sheet (from 2014 to 2024)

Total liabilities by year

Year Total liabilities Change
2023-12-31โ‚น3.34 B-28.97%
2022-12-31โ‚น4.71 B17.58%
2021-12-31โ‚น4.00 B65.47%
2020-12-31โ‚น2.42 B19.71%
2019-12-31โ‚น2.02 B-52.11%
2018-12-31โ‚น4.22 B262.74%
2017-12-31โ‚น1.16 B159.97%
2016-12-31โ‚น0.44 B333.69%
2015-12-31โ‚น0.10 B-95.72%
2014-12-31โ‚น2.41 B67.39%
2013-12-31โ‚น1.44 B

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
โ‚น2.38 B-46.26%๐Ÿ‡บ๐Ÿ‡ธ USA